首页> 中文期刊>中国医学创新 >长期留置中心静脉导管在血液透析患者中的临床应用研究

长期留置中心静脉导管在血液透析患者中的临床应用研究

     

摘要

目的:观察长期留置中心静脉导管(TCC)在血液透析中的可行性。方法:30例无法建立血管内瘘的患者,采用Permcath双腔导管作右侧颈内静脉内置入。结果:30例均一次性置管成功,期间发生血栓形成或血流不畅2例,感染2例,出血2例,经处理后消失。除4例死亡外(非导管因素),其余均在继续透析中,血流量在200~300 mL/min之间。透析充分性与动静脉内瘘(AVF)患者比较差异无统计学意义(P>0.05)。结论:TCC长期导管安全性能高,能满足临床透析需要,为维持性透析患者建立血管通路的极好补充形式。%Objective:To observe the feasibility of the clinical application the tunneled cuffed catheter(TCC)in hemodialysis. Method:Thirty patients who cannot be established endovascular fistula were adopted in Permcath dual cavity catheter which was put in the right internal jugular vein. Result:Thirty cases were all succeeded in catheter,and thrombosis or poor blood flow occurred in 2 cases,infection in 2 cases,hemorrhaged in 2 cases, which disappeared after the treatment. Except 4 cases died(Not-TCC factors),the rest were on dialysis,whose blood flowed from 200 to 300 mL/min. There was no difference between TCC and Arteriovenous fistula(AVF)in dialysis adequacy(P>0.05). Conclusion:TCC is safe enough to meet the clinical dialysis,which is an optimal and alternative vascular access for maintenance patients in hemodialysis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号